Terry J. Rosen, Chief Executive Officer at Arcus Biosciences, Inc. (RCUS), bought 43,502 shares at $12.57 ($551K) on 2018-08-15, disclosed to the SEC on 2018-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.36 | 6,169 | $76K | 13.8% |
| 2 | $12.36 | 6,169 | $76K | 13.8% |
| 3 | $12.57 | 13,300 | $167K | 30.3% |
| 4 | $12.95 | 8,932 | $116K | 21.0% |
| 5 | $12.95 | 8,932 | $116K | 21.0% |
| Total | $12.67 avg | 43,502 |
| $551K |
| 100% |
| Filing → |
| RCUS | SELL | 2022-12-16 | $802K | — | Filing → |
| RCUS | SELL | 2022-06-21 | $350K | — | Filing → |
| RCUS | SELL | 2021-12-20 | $277K | — | Filing → |